Article

barrons.com on 2022-01-28 11:39

Biogen Sells Stake in Biosimilars Venture for $2.3 Billion1 min read

Biogen will be selling its stake in a biosimilars joint venture to partner Samsung Biologics for up to $2.3 billion.

Related news